1-113901822-T-G
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001253852.3(AP4B1):c.402A>C(p.Ser134Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0393 in 1,614,146 control chromosomes in the GnomAD database, including 1,578 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S134S) has been classified as Likely benign.
Frequency
Consequence
NM_001253852.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- AP-4 deficiency syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hereditary spastic paraplegia 47Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- AP4-related intellectual disability and spastic paraplegiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP4B1 | NM_001253852.3 | c.402A>C | p.Ser134Ser | synonymous_variant | Exon 3 of 10 | ENST00000369569.6 | NP_001240781.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0288 AC: 4383AN: 152168Hom.: 110 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0364 AC: 9151AN: 251470 AF XY: 0.0394 show subpopulations
GnomAD4 exome AF: 0.0404 AC: 59114AN: 1461860Hom.: 1466 Cov.: 32 AF XY: 0.0417 AC XY: 30304AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0288 AC: 4387AN: 152286Hom.: 112 Cov.: 32 AF XY: 0.0286 AC XY: 2132AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Hereditary spastic paraplegia 47 Benign:2
- -
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hereditary spastic paraplegia Benign:1
- -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at